Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWise Group Regulatory News (WISE)

Share Price Information for Wise Group (WISE)

Share Price is delayed by 15 minutes
Get Live Data
826.00    0.00 (0.00%)
Bid:
770.00
Ask:
0.00
Spread: 56.00 (7.273%)
Market Cap: £8.26b
WISE Live PriceLast checked at - London Stock Exchange

Intraday Wise Group Share Chart

Establishment of Euro Medium Term Note Programme

13 Nov 2025 09:14

RNS Number : 4266H
Wise PLC
13 November 2025
 

Wise Financing plc - LEI: 6488E9H7Z3K04JNN7302Wise plc - LEI: 213800LD9XCHIC1C4V71

 

THIS ANNOUNCEMENT IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW

 

 

13 November 2025

 

WISE FINANCING PLC

 

ESTABLISHMENT OF EURO MEDIUM TERM NOTE PROGRAMME AND PUBLICATION OF ADMISSION PARTICULARS

 

 

Wise Financing plc, a wholly-owned finance subsidiary of Wise Financial Holdings Limited (a wholly-owned subsidiary of Wise plc), today announces the establishment of its Euro Medium Term Note Programme (the "Programme").

 

As part of the Programme establishment, the following admission particulars (the "Admission Particulars") have been submitted to and approved by the International Securities Market of the London Stock Exchange:

 

Admission Particulars dated 13 November 2025 relating to the Euro Medium Term Note Programme of Wise Financing plc, as Issuer, which is unconditionally and irrevocably guaranteed by Wise plc, as Parent Guarantor, and certain of its subsidiaries.

 

A copy of the Admission Particulars can be viewed on Wise plc's website at https://wise.com/owners/debt-issuance.

 

This website is not provided for, or directed at, U.S. persons or persons in the United States. If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.

 

Enquiries

Martin Adams - Owner Relationsowners@wise.com

Sana Rahman - Communicationspress@wise.com

Brunswick GroupCharles Pretzlik / Emily Murphywise@brunswickgroup.com +44 (0) 20 7404 5959

 

About Wise

 

Wise is a global technology company, building the best way to move and manage the world's money.With Wise Account and Wise Business, people and businesses can hold 40 currencies, move money between countries and spend money abroad. Large companies and banks use Wise technology too; an entirely new network for the world's money. Launched in 2011, Wise is one of the world's fastest growing, profitable tech companies.

In fiscal year 2025, Wise supported around 15.6 million people and businesses, processing over $197 billion in cross-border transactions and saving customers around $2.7 billion.

 

DISCLAIMER - INTENDED ADDRESSES

Please note that the information contained in the Admission Particulars may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Admission Particulars) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Admission Particulars is not addressed. Prior to relying on the information contained in the Admission Particulars you must ascertain from the Admission Particulars whether or not you are part of the intended addressees of the information contained therein.

The Admission Particulars do not constitute an offer of securities for sale in the United States. The notes described herein and in the Admission Particulars have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold to U.S. persons or to persons within the United States of America (as such terms are defined in Regulation S under the Securities Act) , except pursuant to an exemption from the Securities Act. For a further description of certain restrictions on offers and sales of the notes and on distribution of the Admission Particulars, see the "Subscription and Sale" section in the Admission Particulars.

Your right to access this service is conditional upon complying with the above requirement.

No offer or invitation to acquire any securities is being made pursuant to this announcement.

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGCBDBDBBDGUX
Date   Source Headline
6th Nov 20247:00 amRNSUnaudited interim results for period ended 30/9/24
1st Nov 20241:23 pmRNSTotal Voting Rights
28th Oct 20247:00 amRNSFCA concludes investigation into Kristo Käärmann
16th Oct 202411:35 amRNSDirector/PDMR Shareholding
15th Oct 20247:00 amRNSQ2 Trading Update
1st Oct 20245:20 pmRNSTotal Voting Rights
18th Sep 20244:58 pmRNSResult of AGM
3rd Sep 202410:22 amRNSTotal Voting Rights
28th Aug 20247:00 amRNSDirector/PDMR Shareholding
19th Aug 20243:33 pmRNSDirector/PDMR Shareholding
14th Aug 202412:36 pmRNSDirector/PDMR Shareholding
12th Aug 20247:00 amRNSBlock listing Interim Review
9th Aug 20249:24 amRNSNotice of AGM
8th Aug 202410:21 amRNSHolding(s) in Company
1st Aug 202410:30 amRNSTotal Voting Rights
29th Jul 202412:50 pmRNSPDMR Shareholding
24th Jul 202410:47 amRNSDirector/PDMR Shareholding
19th Jul 20243:39 pmRNSDirector/PDMR Shareholding
17th Jul 20243:04 pmRNSDirector/PDMR Shareholding
16th Jul 20247:00 amRNS1st Quarter Results
12th Jul 20241:16 pmRNSAnnual Financial Report
5th Jul 20241:55 pmRNSDirector/PDMR Shareholding
1st Jul 20247:00 amRNSTotal Voting Rights
19th Jun 20245:11 pmRNSDirector/PDMR Shareholding
19th Jun 20241:56 pmRNSDirector/PDMR Shareholding
18th Jun 20247:00 amRNSDirector/PDMR Shareholding
14th Jun 202412:18 pmRNSDirector/PDMR Shareholding
13th Jun 20247:00 amRNSWISE PLC PRELIMINARY RESULTS FY END 31 MARCH 2024
3rd Jun 20244:36 pmRNSTotal Voting Rights
29th May 202410:39 amRNSPresentation of financial information
2nd May 202410:02 amRNSTotal Voting Rights
26th Apr 20244:01 pmRNSDirector/PDMR Shareholding
24th Apr 20244:32 pmRNSDirector/PDMR Shareholding
22nd Apr 20243:12 pmRNSDirector/PDMR Shareholding
22nd Apr 20247:00 amRNSDirector/PDMR Shareholding
18th Apr 20249:33 amRNSHolding(s) in Company
17th Apr 20247:00 amRNSDirector/PDMR Shareholding
16th Apr 20243:03 pmRNSHolding(s) in Company
16th Apr 20247:00 amRNSWISE PLC Q4FY24 TRADING UPDATE
25th Mar 20247:00 amRNSManagement Update
15th Mar 202412:43 pmRNSHolding(s) in Company
15th Mar 202412:35 pmRNSTotal Voting Rights
1st Mar 20242:03 pmRNSTotal Voting Rights
6th Feb 20245:08 pmRNSDirector/PDMR Shareholding
2nd Feb 20249:22 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSTotal Voting Rights
30th Jan 202412:01 pmRNSHolding(s) in Company
24th Jan 202412:01 pmRNSDirector/PDMR Shareholding
23rd Jan 20249:49 amRNSDirector/PDMR Shareholding
22nd Jan 20244:07 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.